BET protein inhibitors including I-BET762, CPI-0610, and TEN-010, as well as the Kub reader p97/VCP inhibitor CB-5083, are in clinical trials for several solid tumors and hematological malignancies [6,271,272]. The gene discussed is VCP; the disease is hematologic disorder.